Close

Kura Oncology (KURA) Presents Data from HRAS Mutant Solid Tumors Phase 2 Trial at ESOC-9

Go back to Kura Oncology (KURA) Presents Data from HRAS Mutant Solid Tumors Phase 2 Trial at ESOC-9